Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets.

mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets. Abstract Text:

    andrew s weyrichAndrew S Weyrich,melvin m denisMelvin M Denis,hansjorg schwertzHansjorg Schwertz,neal d tolleyNeal D Tolley,jason foulksJason Foulks,eliott spencerEliott Spencer,larry w kraissLarry W Kraiss,kurt h albertineKurt H Albertine,thomas m mcintyreThomas M McIntyre,guy a zimmermanGuy A Zimmerman,andrew s weyrichAndrew S Weyrich,melvin m denisMelvin M Denis,hansjorg schwertzHansjorg Schwertz,neal d tolleyNeal D Tolley,jason foulksJason Foulks,eliott spencerEliott Spencer,larry w kraissLarry W Kraiss,kurt h albertineKurt H Albertine,thomas m mcintyreThomas M McIntyre,guy a zimmermanGuy A Zimmerman,

    New activities of human platelets continue to emerge. One unexpected response is new synthesis of proteins from previously transcribed RNAs in response to activating signals. We previously reported that activated human platelets synthesize B-cell lymphoma-3 (Bcl-3) under translational control by mammalian target of rapamycin (mTOR). Characterization of the ontogeny and distribution of the mTOR signaling pathway in CD34+ stem cell-derived megakaryocytes now demonstrates that they transfer this regulatory system to developing proplatelets. We also found that Bcl-3 is required for condensation of fibrin by activated platelets, demonstrating functional significance for mTOR-regulated synthesis of the protein. Inhibition of mTOR by rapamycin blocks clot retraction by human platelets. Platelets from wild-type mice synthesize Bcl-3 in response to activation, as do human platelets, and platelets from mice with targeted deletion of Bcl-3 have defective retraction of fibrin in platelet-fibrin clots mimicking treatment of human platelets with rapamycin. In contrast, overexpression of Bcl-3 in a surrogate cell line enhanced clot retraction. These studies identify new features of post-transcriptional gene regulation and signal-dependant protein synthesis in activated platelets that may contribute to thrombus and wound remodeling and suggest that posttranscriptional pathways are targets for molecular intervention in thrombotic disorders.

    mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets. Publishing Authors By Initials

    as weyrichAS Weyrich,mm denisMM Denis,h schwertzH Schwertz,nd tolleyND Tolley,j foulksJ Foulks,e spencerE Spencer,lw kraissLW Kraiss,kh albertineKH Albertine,tm mcintyreTM McIntyre,ga zimmermanGA Zimmerman,as weyrichAS Weyrich,mm denisMM Denis,h schwertzH Schwertz,nd tolleyND Tolley,j foulksJ Foulks,e spencerE Spencer,lw kraissLW Kraiss,kh albertineKH Albertine,tm mcintyreTM McIntyre,ga zimmermanGA Zimmerman,

    For similar proteins: transcription factors research abstracts see: proteins: transcription factors research

    PUBMED ID PMID:

    MEDLINE DATE:

    mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Blood

    VOLUME: 109

    Page Numbers: 1975-83

    Journal Abbreviation: Blood

    ISSN: 0006-4971

    DAY: 16

    MONTH: 11

    YEAR: 2006

    mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7603509

    mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets. Keywords Mesh Terms:

    KEYWORDS: Transcription Factors

    MESH TERMS: genetics

    Chemical & Substance for Abstract: mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets. Information

    Substance Name: Protein Kinases

    Registry Number: EC 2.7.1.37

    Grant and Affiliation Information for mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets.

    AFFILIATION: Department of Internal Medicine, Eccles Institute of Human Genetics, University of Utah, Salt Lake City, UT 84112, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NHLBI

    GRANT: HL-75507

    ACRONYM: HL

    MEDLINETA: Blood

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News